
Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Labo
Description
Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Others) and Regional Forecasts, 2022-2032
Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Others) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW
Clinical Diagnostics Market size was USD 66.86 billion in 2021 and projected to grow from USD 75.9 billion in 2023 to USD 135.5 billion by 2032, exhibiting a CAGR of 6.6% during the forecast period.
Clinical diagnostic services give physicians a variety of instruments to aid in decision making related to best therapy required for patients with different diseases. The frequency of chronic and infectious diseases is increasing along with the implementation of automated platforms which is anticipated to boost the market growth. Clinical diagnostics denotes the process of recognising, identifying and observing disease through signs, symptoms, physical examination of a patient. They help in disease management to enhance health and well-being along with the classification of patients with diverse diseases.
MARKET HIGHLIGHTS
Clinical Diagnostics Market is expected to reach USD 135.5 billion, growing at a CAGR of 6.6% during forecast period owing to the factors like changing lifestyles of individuals with unhealthy habits, which resulted in acquiring diseases like hypertension, diabetes, and cardiovascular issues. Growing digital participation permit consumers to involve in clinical outcomes, high operational cost-cutting which is expected to boost the market growth during the forecast period. Increasing acceptance of non-invasive prenatal testing created attention for implementation of innovative nanomaterials, and point-of-care medical diagnostics which is anticipated to drive the demand for the market growth.
Clinical Diagnostics Market Segments:
- Test
- Liver Panel
- Lipid Panel
- Renal Panel
- Electrolyte Testing
- Complete Blood Count
- Infectious Disease Testing
- Others
- Product
- Reagents
- Instruments
- Others
- End User
- Diagnostic Laboratory
- Hospital Laboratory
- Point-of-care Testing
- Others
Growth Drivers
Increasing Demand for Clinical Diagnostic is Expected to Boost the Market Growth
Increasing Incidence of Chronic Diseases is Expected to Boost the Growth of the Market
Restraint
Easy Availability of Molecular Diagnostics May Restrain the Growth of the Market
Key Players
- BioMerieux
- ARUP Laboratories
- Becton, Dickinson, and Company
- Abbott Laboratories
- Qiagen
- Bio-Reference Laboratories
- Labcorp
- Bioscientia Healthcare
- Danaher Corporation
- Quest Diagnostics Inc.
- Hologic Inc.
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific
- Sonic Healthcare Ltd
- Sysmex Corporation
- Siemens AG
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
304 Pages
- 1. Executive Summary
- 1.1.Regional Market Share
- 1.2. Business Trends
- 1.3. Clinical Diagnostics Market: COVID-19 Outbreak
- 1.4.Regional Trends
- 1.5. Segmentation Snapshot
- 2. Research Methodology
- 2.1. Research Objective
- 2.2.Research Approach
- 2.3.Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1.Paid Sources
- 2.5.2. Public Sources
- 2.6.Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1. Market Definition
- 3.2.Clinical Diagnostics Market: COVID-19 Impact
- 3.3.Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4. Clinical Diagnostics Market – Industry Insights
- 4.1.Industry Segmentation
- 4.2. COVID-19 overview on world economy
- 4.3. Industry ecosystem Channel analysis
- 4.4. Innovation & Sustainability
- 5. Macroeconomic Indicators
- 6. Recent Developments
- 7.Market Dynamics
- 7.1. Introduction
- 7.2.Growth Drivers
- 7.3.Market Opportunities
- 7.4. Market Restraints
- 7.5.Market Trends
- 8. Risk Analysis
- 9. Market Analysis
- 9.1. Porters Five Forces
- 9.2.PEST Analysis
- 9.2.1. Political
- 9.2.2.Economic
- 9.2.3.Social
- 9.2.4.Technological
- 10. Clinical Diagnostics Market
- 10.1.Overview
- 10.2. Historical Analysis (2016-2021)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11.Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 11.1.Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1.By Test
- 11.3.1.1. Liver Panel
- 11.3.1.1.1. By Value (USD Million) 2022-2032F
- 11.3.1.1.2.Market Share (%) 2022-2032F
- 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.1.2.Lipid Panel
- 11.3.1.2.1.By Value (USD Million) 2022-2032F
- 11.3.1.2.2. Market Share (%) 2022-2032F
- 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.3.Renal Panel
- 11.3.1.3.1.By Value (USD Million) 2022-2032F
- 11.3.1.3.2. Market Share (%) 2022-2032F
- 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.4.Electrolyte Testing
- 11.3.1.4.1.By Value (USD Million) 2022-2032F
- 11.3.1.4.2. Market Share (%) 2022-2032F
- 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.5.Complete Blood Count
- 11.3.1.5.1.By Value (USD Million) 2022-2032F
- 11.3.1.5.2. Market Share (%) 2022-2032F
- 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.6.Infectious Disease Testing
- 11.3.1.6.1.By Value (USD Million) 2022-2032F
- 11.3.1.6.2. Market Share (%) 2022-2032F
- 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.7.Others
- 11.3.1.7.1.By Value (USD Million) 2022-2032F
- 11.3.1.7.2. Market Share (%) 2022-2032F
- 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2. By Product
- 11.3.2.1.Reagents
- 11.3.2.1.1.By Value (USD Million) 2022-2032F
- 11.3.2.1.2. Market Share (%) 2022-2032F
- 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.2. Instruments
- 11.3.2.2.1. By Value (USD Million) 2022-2032F
- 11.3.2.2.2.Market Share (%) 2022-2032F
- 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.2.3. Others
- 11.3.2.3.1. By Value (USD Million) 2022-2032F
- 11.3.2.3.2.Market Share (%) 2022-2032F
- 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.3. By End User
- 11.3.3.1.Diagnostic Laboratory
- 11.3.3.1.1.By Value (USD Million) 2022-2032F
- 11.3.3.1.2. Market Share (%) 2022-2032F
- 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.2. Hospital Laboratory
- 11.3.3.2.1. By Value (USD Million) 2022-2032F
- 11.3.3.2.2.Market Share (%) 2022-2032F
- 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.3.3. Point-of-care Testing
- 11.3.3.3.1. By Value (USD Million) 2022-2032F
- 11.3.3.3.2.Market Share (%) 2022-2032F
- 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.3.4. Others
- 11.3.3.4.1. By Value (USD Million) 2022-2032F
- 11.3.3.4.2. Market Share (%) 2022-2032F
- 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
- 12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Test
- 12.3.2.By Product
- 12.3.3.By End User
- 12.4. Country
- 12.4.1.United States
- 12.4.2. Canada
- 13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Test
- 13.3.2.By Product
- 13.3.3.By End User
- 13.4. Country
- 13.4.1.Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 14.1.Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Test
- 14.3.2.By Product
- 14.3.3.By End User
- 14.4. Country
- 14.4.1.India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 15.1.Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Test
- 15.3.2.By Product
- 15.3.3.By End User
- 15.4. Country
- 15.4.1.Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Test
- 16.3.2.By Product
- 16.3.3.By End User
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17. Competitive Landscape
- 17.1. Company market share, 2021
- 17.2.Key player overview
- 17.3. Key stakeholders
- 18. Company Profiles
- 18.1.BioMerieux
- 18.1.1.Company Overview
- 18.1.2.Financial Overview
- 18.1.3.Key Product; Analysis
- 18.1.4.Company Assessment
- 18.1.4.1.Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. ARUP Laboratories
- 18.3. Becton, Dickinson, and Company
- 18.4.Abbott Laboratories
- 18.5. Qiagen
- 18.6. Bio-Reference Laboratories
- 18.7. Labcorp
- 18.8.Bioscientia Healthcare
- 18.9. Danaher Corporation
- 18.10.Quest Diagnostics Inc.
- 18.11.Hologic Inc.
- 18.12.F. Hoffmann-La Roche AG
- 18.13.Thermo Fisher Scientific
- 18.14.Sonic Healthcare Ltd
- 18.15.Sysmex Corporation
- 18.16. Siemens AG
- 18.17. Other Prominent Players
- 19. Appendix
- 20.Consultant Recommendation
- 1. Executive Summary
- 1.1.Regional Market Share
- 1.2. Business Trends
- 1.3. Clinical Diagnostics Market: COVID-19 Outbreak
- 1.4.Regional Trends
- 1.5. Segmentation Snapshot
- 2. Research Methodology
- 2.1. Research Objective
- 2.2.Research Approach
- 2.3.Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1.Paid Sources
- 2.5.2. Public Sources
- 2.6.Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1. Market Definition
- 3.2.Clinical Diagnostics Market: COVID-19 Impact
- 3.3.Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4. Clinical Diagnostics Market – Industry Insights
- 4.1.Industry Segmentation
- 4.2. COVID-19 overview on world economy
- 4.3. Industry ecosystem Channel analysis
- 4.4. Innovation & Sustainability
- 5. Macroeconomic Indicators
- 6. Recent Developments
- 7.Market Dynamics
- 7.1. Introduction
- 7.2.Growth Drivers
- 7.3.Market Opportunities
- 7.4. Market Restraints
- 7.5.Market Trends
- 8. Risk Analysis
- 9. Market Analysis
- 9.1. Porters Five Forces
- 9.2.PEST Analysis
- 9.2.1. Political
- 9.2.2.Economic
- 9.2.3.Social
- 9.2.4.Technological
- 10. Clinical Diagnostics Market
- 10.1.Overview
- 10.2. Historical Analysis (2016-2021)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11.Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 11.1.Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1.By Test
- 11.3.1.1. Liver Panel
- 11.3.1.1.1. By Value (USD Million) 2022-2032F
- 11.3.1.1.2.Market Share (%) 2022-2032F
- 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.1.2.Lipid Panel
- 11.3.1.2.1.By Value (USD Million) 2022-2032F
- 11.3.1.2.2. Market Share (%) 2022-2032F
- 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.3.Renal Panel
- 11.3.1.3.1.By Value (USD Million) 2022-2032F
- 11.3.1.3.2. Market Share (%) 2022-2032F
- 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.4.Electrolyte Testing
- 11.3.1.4.1.By Value (USD Million) 2022-2032F
- 11.3.1.4.2. Market Share (%) 2022-2032F
- 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.5.Complete Blood Count
- 11.3.1.5.1.By Value (USD Million) 2022-2032F
- 11.3.1.5.2. Market Share (%) 2022-2032F
- 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.6.Infectious Disease Testing
- 11.3.1.6.1.By Value (USD Million) 2022-2032F
- 11.3.1.6.2. Market Share (%) 2022-2032F
- 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.7.Others
- 11.3.1.7.1.By Value (USD Million) 2022-2032F
- 11.3.1.7.2. Market Share (%) 2022-2032F
- 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2. By Product
- 11.3.2.1.Reagents
- 11.3.2.1.1.By Value (USD Million) 2022-2032F
- 11.3.2.1.2. Market Share (%) 2022-2032F
- 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.2. Instruments
- 11.3.2.2.1. By Value (USD Million) 2022-2032F
- 11.3.2.2.2.Market Share (%) 2022-2032F
- 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.2.3. Others
- 11.3.2.3.1. By Value (USD Million) 2022-2032F
- 11.3.2.3.2.Market Share (%) 2022-2032F
- 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.3. By End User
- 11.3.3.1.Diagnostic Laboratory
- 11.3.3.1.1.By Value (USD Million) 2022-2032F
- 11.3.3.1.2. Market Share (%) 2022-2032F
- 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.2. Hospital Laboratory
- 11.3.3.2.1. By Value (USD Million) 2022-2032F
- 11.3.3.2.2.Market Share (%) 2022-2032F
- 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.3.3. Point-of-care Testing
- 11.3.3.3.1. By Value (USD Million) 2022-2032F
- 11.3.3.3.2.Market Share (%) 2022-2032F
- 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.3.4. Others
- 11.3.3.4.1. By Value (USD Million) 2022-2032F
- 11.3.3.4.2. Market Share (%) 2022-2032F
- 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
- 12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Test
- 12.3.2.By Product
- 12.3.3.By End User
- 12.4. Country
- 12.4.1.United States
- 12.4.2. Canada
- 13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Test
- 13.3.2.By Product
- 13.3.3.By End User
- 13.4. Country
- 13.4.1.Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 14.1.Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Test
- 14.3.2.By Product
- 14.3.3.By End User
- 14.4. Country
- 14.4.1.India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 15.1.Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Test
- 15.3.2.By Product
- 15.3.3.By End User
- 15.4. Country
- 15.4.1.Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Test
- 16.3.2.By Product
- 16.3.3.By End User
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17. Competitive Landscape
- 17.1. Company market share, 2021
- 17.2.Key player overview
- 17.3. Key stakeholders
- 18. Company Profiles
- 18.1.BioMerieux
- 18.1.1.Company Overview
- 18.1.2.Financial Overview
- 18.1.3.Key Product; Analysis
- 18.1.4.Company Assessment
- 18.1.4.1.Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. ARUP Laboratories
- 18.3. Becton, Dickinson, and Company
- 18.4.Abbott Laboratories
- 18.5. Qiagen
- 18.6. Bio-Reference Laboratories
- 18.7. Labcorp
- 18.8.Bioscientia Healthcare
- 18.9. Danaher Corporation
- 18.10.Quest Diagnostics Inc.
- 18.11.Hologic Inc.
- 18.12.F. Hoffmann-La Roche AG
- 18.13.Thermo Fisher Scientific
- 18.14.Sonic Healthcare Ltd
- 18.15.Sysmex Corporation
- 18.16. Siemens AG
- 18.17. Other Prominent Players
- 19. Appendix
- 20.Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.